alexa Neurocognition in Patients with Acne Vulgaris | OMICS International
ISSN: 2378-5756
Journal of Psychiatry
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Neurocognition in Patients with Acne Vulgaris

Erdem Deveci1*, Ahmet Öztürk2, Ismet Kırpınar1, Ahmet Koyuncu3, Ismail Engin4, Mehmet Melikoğlu4, Enver Demirel Yılmaz1 and Emel Koçer1

1Bezmialem Vakif University, School of Medicine, Department of Psychiatry, İstanbul, Turkey

2Dumlupınar University, School of Medicine, Department of Psychiatry, Kütahya, Turkey

3Incirli Ethica Hospital, Department of Psychiatry, İstanbul, Turkey

4Regional Training and Research Hospital, Department of Dermatology, Erzurum, Turkey

*Corresponding Author:
Erdem Deveci
Bezmialem Vakıf Üniversitesi
Hastanesi Psikiyatri Kliniği Vatan Caddesi
34093 Fatih, İstanbul, Turkey
Tel: 905055836796
Fax: 902126217580
E-mail: [email protected]

Received date: March 03, 2014; Accepted date: April 24, 2014; Published date: April 30, 2014

Citation: Deveci E, Öztürk A, Kırpınar I, Koyuncu A, Engin I, et al. (2014) Neurocognition in Patients with Acne Vulgaris. J Psychiatry 17:121. doi: 10.4172/Psychiatry.1000121

Copyright: © 2014 Deveci E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Psychiatry


Memory; Executive functions; Attention; Anxiety; Depression; Acne vulgaris


Acne is the most common visible skin disease. The relationship between acne and mental health has been extensively studied [1]. Emotional stress can exacerbate acne, and acne patients may experience psychological and psychiatric problems [2]. Psychological problems associated with acne include a decrease in self-esteem, impaired overall perception of personal well-being and self-image, embarrassment, fear of rejection, social withdrawal, anger, restrictions in lifestyle, problematic family relations, and excessive mental engagement in the acne lesions [2-5]. Depression, anxiety, social phobia, and body dysmorphic disorder are common psychiatric disorders in patients with acne, and the reported prevalence of suicidal ideation and suicide completion in acne patients is remarkable [6]. The mental health impairment scores among acne patients are higher when compared with a variety of other chronic, non-psychiatric medical conditions, including epilepsy and diabetes [7]. Mallon et al. [8] compared the quality of life of 111 acne patients with that of patients with other organic diseases using the SF-36 quality of life scale and found that emotional and psychological problems in acne patients are as serious as those observed in asthma, epilepsy, diabetes, and arthritis patients.

Patients with depression, social anxiety disorder, and social phobia show neuropsychological symptoms and these disorders are common associated with impairment of neurocognitive skills, including reduced memory, attention, psychomotor speed, and executive functions [9,10].

Taking into account that acne vulgaris is largely a disease of adolescence, a period in which academic performance has great importance and acne is often associated with psychiatric problems affecting cognitive functionality, it seems to be important to evaluate the impact of acne on cognitive functions.

We searched the literature and did not find any study evaluating the cognitive functions of acne patients. In our recent study on the effects of isotretinoin treatment on cognitive abilities, we found improvements in attention and executive functions during isotretinoin treatment [11]. In that study we did not aim to evaluate the baseline cognitive performances of acne patients in comparison with healthy controls and it was unclear whether the results showed an ongoing cognitive impairment before the isotretinoin treatment or not. We designed this study to answer this question and we determined the cognitive functioning in treatment naive acne patients, without a history of any psychiatric disorder, or active psychopathology.



We recruited 66 consecutive patients referred to the dermatology outpatient clinic and 47 healthy controls matched with the patient group for age, gender and years of education. Controls were the neighbours of the hospital staff. The study protocol fulfilled the principles outlined in the Declaration of Helsinki and was approved by the local Ethics Committee. All participants were informed about the protocol and a written consent was obtained from each one.

A thorough clinical evaluation including a detailed medical and psychiatric history, and a complete physical examination was performed for each participant (patients and controls). In addition, the diagnosis and clinical classifications of acne were determined by a dermatologist.

The Turkish equivalent of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) was applied by a psychiatrist to all participants. The participants that had a diagnosis or a history of mental retardation (IQ<70), serious head trauma, seizures or any other mental disorder (including schizophrenia and other psychotic disorders, attention deficit hyperactivity disorder, learning disorders, pervasive developmental disorders, mood disorders, obsessive compulsive disorder, and anxiety disorders meeting the diagnostic criteria), and participants on any medical treatment were excluded. Participants with a family history (first degree relatives) of schizophrenia, bipolar disorder or schizoaffective disorder were also excluded to avoid the negative effect of these disorders on cognitive functions. The same exclusion criteria were also applied to the control group.

Neurocognitive evaluation and IQ assessment

IQ test and cognitive assessments were conducted in the test laboratory of our clinic. Optimal requirements for testing, such as room lighting, silence, and the physiological necessities of the subjects were fulfilled. To avoid the confounding effect of time of the day on cognitive functions, all the tests were applied between 09.00 and 11.00 A.M. We used Kent-EGY and Porteus labyrynths tests for the assessment of IQ. We used a neurocognitive battery, which comprised of the Rey Auditory Verbal Learning Test (RAVLT), Auditory Consonant Trigram Test (ACTT), Controlled Oral Word Association Test (COWAT), Digit Span Test (DST), Trail Making Test and Stroop Test (TMT-A/-B). The administration procedures for the neurocognitive tests used in the present study are provided below.

Rey auditory verbal learning and memory test

Verbal episodic memory and learning was assessed with the RAVLT, in which subjects were required to learn a series of words presented orally over five trials and were then asked to immediately recall them after each presentation (total recall of five trials), or after a 20 min delay (delayed recall). They were also asked to recognize and mark target words between distracters (recognition) on a paper. The following measures were analyzed; Total learning scores (1-5): The total number of correctly recalled words aggregated over the five learning trials. Delayed recall: The total number of correctly recalled words after the 20 min delay. True positives: The number of true answers that the subject was expected to mark in the recognition section of the test. True negatives: The number of true answers that the subject was expected not to mark in the recognition section of the test. Recognition percent correct score: This measure is calculated by the formula: True positives + True negatives / 50, as proposed by Harris et al. [12].

Auditory consonant trigram test

This test is used to measure attention and working memory. The subject listened to a string of three consonants (the consonant trigram), and this is immediately followed by a mental task, such as counting backward. After that task, the client was asked to recall the trigram. The total number of recalled letters was used in evaluation [13].

Controlled oral word association test

This test is a measure of phonemic verbal fluency. Subjects had to produce a maximum number of words with the given letters (K, A and S, according to Turkish standardization), with 1 min allowed for each letter [14].

Digit span test

This test measures attention and working memory. It had two sections, Digit Span Forward and Backward. In the forward section, the subject repeated the numbers told to him/her by the examiner. In the backward section, the subject repeated the numbers told to him/her backward. The participant’s score was the sum of the correctly recalled numbers in the forward and backward sections, and the total correctly recalled numbers of both the sections combined [13].

Trail making test

This TMT assesses mental flexibility, visual tracking and motor abilities. It consisted of two parts [13,15]. In part A, dots numbered between 1 and 25 were combined with a continuous line and in part B, each letter was combined with a number. Part A evaluated psychomotor speed and focused attention, whereas part B measured mental flexibility [16]. In this test, the time required to complete the two separate parts was measured.

Stroop test

This test measures word-reading and colour-naming speed, and the participant’s ability to inhibit reading in favour of ink-colour naming, when words were printed in colours different from those spelled out. The Stroop test assessed the ability to flexibly direct attention to the presence of a distraction, inhibit a habitual behavioural pattern, and display non-usual behaviour by taking into account the individual’s speed of processing in measuring resistance to interference [13,17].

Structured clinical interview for DSM-IV axis I disorders (SCID-I)

SCID-I is a diagnostic exam used to determine DSM-IV Axis I disorders and covers diagnoses most commonly seen by clinicians and includes the diagnostic criteria for these disorders with corresponding interview questions. The SCID-I is divided into six self-contained modules that can be administered in sequence: mood episodes; psychotic symptoms; psychotic disorders; mood disorders; substance use disorders; and anxiety, adjustment, and other disorders. The reliability analyses of the Turkish version of SCID-I were performed as per Özkürkçügil et al. [18].

Hospital anxiety and depression scale (HADS)

The Hospital Anxiety and Depression Scale (HADS), a selfassessment scale, was developed to detect states of depression, anxiety and emotional distress amongst patients who were being treated for a variety of clinical problems. The final scale has a total of 14 items, with responses being scored on a scale of 0-3, with 3 indicating higher symptom frequencies. Score for each subscale (anxiety and depression) can range from 0-21 with scores categorized as follows: normal (0-7), mild (8-10), moderate (11-14), severe (15-21). Scores for the entire scale (emotional distress) range from 0-42, with higher scores indicating more distress. Prior to completing the scale patients are asked to “fill it complete in order to reflect how they have been feeling during the past week” The reliability and validity study of the Turkish version was performed as per Aydemir et al. [19].

Liebowitz social anxiety scale (LSAS)

LSAS was developed in the 1980’s to facilitate the measurement of distress and impairment caused by social anxiety. The scale is comprised of 13 items that measure fear of performance situations and 11 items that measure fear of social interaction. For each of these 24 items avoidance is also measured. The validity and reliability analyses of the Turkish version of the LSAS were performed as per Soykan et al. [20].

Statistical analyses

Statistical analysis was performed using SPSS (version 16.0). The normality distribution of test scores was tested by the Kolmogorov- Smirnov and Shapiro-Wilk tests. The differences between patients and controls were analyzed by Student’s t-test. The values were presented as mean ± standard deviation (SD), or percentages. Analysis of covariance (ANCOVA) was conducted to compare groups on cognitive functioning, covarying HADS and LSAS scores. All statistics are reported in two-tailed form. A P<0.05 was considered statistically significant. A Bonferroni correction was applied to adjust for multiple comparisons.



We recruited 66 consecutive acne patients referred to the dermatology outpatient clinic and 47 healthy controls, who were matched with the patient group for age, gender and years of education, were recruited from the general population. In psychiatric evaluation of the acne patients, 3 were diagnosed with major depressive disorder, 2 with obsessive compulsive disorder, 1 with schizophrenia, two of the patients reported that one of their parents were diagnosed with schizoaffective disorder or schizophrenia and these patients were excluded from the study. 5 patients refused to complete the tests. One of them could not complete the neurocognitive assessment due to physical complaints, such as headache and dizziness. Thus, our analysis was carried out on 52 acne patients and 47 controls.

Acne grades

In the dermatological evaluation of 52 patients, acneic lesions were evaluated in 4 grades based on the localization and number of lesions, according to the classification proposed by Orfonos [21]. The number of patients representing each grade is provided in Table 1.

Variable Mean / Frequency Percentage
  Mean (sd) 36.17 (14.55)  
18-25 10 9.6
26-45 72 69.2
>45 22 21.2
  Male 57 54.2
Female 47 45.2
Marital Status    
  Married 48 46.2
Single 56 53.8
Educational status    
None 24 23.1
Up to Secondary 55 52.9
Tertiary 25 24.0
Unemployed 30 28.8
Self employed 57 58.8
Government employed 17 16.3
Clinical Variables
Level of injury    
Upper Limb 24 23.1
Lower Limb
Type of injury    
Closed fracture 44 42.3
Open fracture 42 40.4
Crush injury 8 7.7
Traumatic amputation 4 3.8
  Multiple injuries 6 5.8
Type of treatment 43 41.3
Conservative (POP traction)
  ORIF 33 31.7
External Fixation 28 26.9
Depressive symptoms    
Present 38 36.5
Absent 66 63.5
Anxiety symptoms 35 33.7
Absent 69 66.3

Table 1: Sociodemographic and Clinical variables.

Socio-demographical features and IQ

As shown in Table 2, the groups were well-matched for age, gender, socioeconomic background, years of education, the type of school, and IQ which are important factors affecting the neurocognitive assessment.

  Variables Posttraumatic stress symptoms
(mean score < 2.0)
N (%)
Posttraumatic stress symptoms
(mean score > 2.0)
N (%)
Chi Square
(P value)
Age in years      
18-25 8 (80.0) 2 (20.0) 8.32 (0.02)
26-45 52 (72.2) 20 (27.8)  
>45 9 (40.9) 13 (59.1)  
Male 46 (80.1) 11(19.9) 11.64
Female 23 (48.9) 24 (51.1) (0.001)
Marital status      
Married 41 (85.4) 7 (14.6) 14.25
Single 28 (50.0) 28 (50.0) (0.001)
Educational level      
None 7 (29.2) 17 (70.8) 20.79
Up to Secondary education 45 (81.2) 10 (18.8) (0.001)
Tertiary education 17 (68.0) 8 (32.0)  
Unemployed 20 (66.7) 10 (33.3) 1.74  (0.42)
Self employed 40 (70.2) 17 (29.8)  
Govt. employed 9 (52.9) 8 (47.1)  
Level of injury      
Upper Limb 18 (75.0) 6 (25.0) 1.05  (0.6)
Lower Limb 46 (63.9) 26 (36.1)  
Others 5 (62.5) 3 (37.5)  
Type of injury      
Closed fracture 28 (63.6) 16 (36.4) 2.63 (0.63)
Open fracture 31 (73.8) 11(26.2)  
Crush injury 4 (50.0) 4 (50.0)  
Traumatic amputation 2 (50.0) 2 (50.0)  
Multiple injuries 4 (66.7) 2 (33.3)  
Type of treatment      
Conservative (POP traction) 28 (65.1) 15 (34.9) 0.25 (0.9)
ORIF* 23 (69.7) 10 (30.3)  
External Fixation 18 (64.3) 10 (35.7)  
Present 9 (23.7) 29 (76.3) 48.81
Absent 60 (90.9) 6 (9.1) (0.0001)

13 (37.1)
56 (81.2)

22 (62.9)
13 (18.8)


Table 2: Association between variables and Posttraumatic Stress Symptoms. *ORIF: Open Reduction and Internal Fixation of fractures.

Neurocognitive assessment

The neurocognitive tests were applied by a psychiatrist. As shown in Table 3, the acne group showed significantly worse performance in verbal episodic memory, learning, working memory, and phonemic verbal fluency, as assessed with the RAVLT, ACTT, COWAT, and DST, when compared to the control group. There were no significant differences between the acne and control groups in terms of executive functioning, attention, mental flexibility, or motor abilities, as assessed by the TMT/A-B and Stroop test.

Neurocognitive Tests Related Cognitive Functions Acne group (n=52) Control group (n=47) Comparison (p) t df
Rey Verbal Learning and Memory Test Verbal episodic memory and          
Total learning scores (1-5)¶**   49.57 ± 7.75 59.09 ± 6.37 <0.0001** -6.62 97
Delayed recalling scores (7)§** learning 9.96  ±1.93 12.60 ± 2.38 <0.0001** -6.00 88.6
True positives ¥   13.81 ± 1.17 14.15 ± 1.33 0.1787 -1.35 97
Recognition percent correct score†   0.95 ± 0.04 0.97 ± 0.04 0.0475* -2.01 97
Auditory Consonant Trigram Test Total scores** Attention and working memory 44.35 ± 7.44 52.32 ± 4.98 <0.0001** -6.19 97
Controlled Word Association Test Total scores** phonemic verbal fluency 32.56 ± 10.65 45.72  ±13.53 <0.0001** -5.40 97
Digit Span Test Attention and working memory          
Forwards section score**   5.88 ± 1.62 7.15 ± 2.01 0.0008** -3.46 97
Backwards section score**   5.38 ± 1.40 6.79  ±2.13 0.0002** -3.91 97
Total scores**   11.27 ± 2.47 13.94 ± 3.73 <0.0001** -4.15 78.5
Trail Making Test mental flexibility and motor abilities          
Part A   28.59 ± 8.95 30.22 ± 10.93 0.4177 -0.81 97
Part B   80.29 ± 52.16 67.02 ± 34.99 0.1372 1.47 89.7
Stroop Test Main Card ‡ Reading Time mental flexibility 22.64  ±7.64 21.11 ± 5.27 0.2538 1.14 97

Table 3: Comparison of study group with healthy controls according to cognitive tests and the cognitive functions related to the tests.

Hospital anxiety and depression and liebowitz social anxiety scale scores

Acne patients scored higher than controls in Hospital anxiety, Liebowitz anxiety, and avoidance scales. There were no significant differences in the hospital depression scores between the control and acne groups (Table 4).

  Acne group (n=52) Control group (n=47) Comparison (p) t df
HADS/Anxiety** 8.34 ± 4.05 6.26 ± 2.77 0.004** 3.01 90.42
HADS/Depression 5.12 ± 2.61 4.69 ± 2.68 0.319 1.002 97
LSAS/Anxiety** 50.17 ± 12.09 42.60 ± 9.58 0.001** 3.42 97
LSAS/Avoidance** 48.33 ± 12.61 37.57 ± 8.93 0.0001** 4.90 90.21

Table 4: Comparisons between acne and control groups according to Hospital Anxiety and Depression Scale (HADS) and Liebowitz Social Anxiety Scale (LSAS) Scores.

Analysis of covariance (ANCOVA) results of cognitive tests of acne and control group after correction for HADS and LSAS scores as covariates.

Taking into account that the groups were significantly different on measures of HADS anxiety and LSAS scores which might have influences on cognitive performance, we conducted Analysis of covariance (ANCOVA) to compare groups on cognitive functioning, controlling for HADS and LSAS scores. As seen on Table 5, the differences between the performances of the groups in cognitive assessment remained significant after covariance.

Dependent Variable Sum of Squares df Mean Square F p
Rey Verbal Learning and Memory Test          
Total learning scores (1-5)¶** 987.315 1 987.315 24.867 <0.001
Delayed recalling scores (7)§** 79.555 1 79.555 20.876 <0.001
True positives ¥ 0.002 1 0.002 0.01 0.970
Recognition percent correct score† 0.001 1 0.001 0.722 0.398
Auditory Consonant Trigram Test Total scores** 1211.832 1 1211.832 29.177 <0.001
Controlled Word Association Test Total scores** 2324.689 1 2324.689 15.917 <0.001
Digit Span Test          
Forwards section score** 29.732 1 29.732 9.085 0.003
Backwards section score** 27.599 1 27.599 8.538 0.004
Total scores** 114.621 1 114.621 11.695 0.001
Trail Making Test          
Part A 176.100 1 176.100 1.782 0.185
Part B 731.013 1 731.013 0.401 0.528
Stroop Test Main Card ‡ Reading Time 16.307 1 16.307 0.362 0.549

Table 5: ANCOVA results of cognitive tests of acne and control group after correction for Hospital Anxiety and Depression Scale (HADS) and Liebowitz Social Anxiety Scale (LSAS) scores as covariates.


The present study demonstrates that acne patients show worse performance in verbal episodic memory, learning, working memory, and phonemic verbal fluency in comparison with controls. No group difference was found in cognitive tests assessing attention or executive functions. We found two studies concerned with cognitive functioning in acne vulgaris patients [22,23]. In addition, our recent study showed improvements in cognitive abilities such as attention and executive functions, during isotretinoin treatment [11]. In the first study, working memory and verbal fluency were tested in acne patients using the digit span backward, forward, digit symbol, and letter fluency tests and were found to be significantly improved after isotretinoin treatment [22]. In the second study, hippocampal-based learning was evaluated using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and was found to be improved significantly after isotretinoin treatment [23].

The active metabolite of isotretinoin, retinoic acid (RA), is synthesized endogenously from vitamin A and acts to regulate cellular proliferation and differentiation, neuronal plasticity, long-term potentiation (LTP), and neurogenesis in the central nervous system (CNS). The hippocampus plays a critical role in episodic and spatial memory, which are dependent on RA regulated functions, such as neuronal plasticity, long-term potentiation, and neurogenesis [24]. RA is also required for neurogenesis in the hippocampus, inducing the expression of neurotrophin receptors [25], and promoting neuronal differentiation and cell survival [23]. The positive influence of isotretinoin on cognition could be due to either its impact on hippocampal function related with retinoid signalling, or alleviation of acne and consequently the reduction in psychological disturbances.

In a retrospective cross-sectional study of epidemiologic databases of 55,825 dermatology outpatient visits from 1995 to 2009, Gupta et al. [26] examined the frequency of Attention Deficit Hyperactivity Disorder (ADHD) in acne versus all other dermatology-related patient visits, and reported that in comparison to other dermatologic disorders, acne was over two-fold more likely to be associated with ADHD, after controlling for the possible confounding effects of age, sex, stimulant medications, co-morbid anxiety, or depressive disorders. Given that attention deficit/hyperactivity disorder has been associated with disturbances of cognitive functions, such as working memory, attention and executive functions, the higher frequency of ADHD in acne patients suggests a relationship between acne and cognitive dysfunctions [27-29]. Gupta et al. [26] also suggest that the significant association of acne with ADHD may contribute to the increased psychological morbidity observed in some acne patients. However we did not find any group differences in cognitive tests assessing attention or executive functions. This might be due to our exclusion criteria including ADHD, family history (first degree relatives) of schizophrenia, bipolar disorder or schizoaffective disorder which is affecting mainly attention or executive functions. On the other hand, our finding that specific cognitive functions in acne patients are influenced might be due to some causes. The psychological distresses which can lead to dysfunctions in cognition, including decreased self-esteem, impaired perception of selfimage, embarrassment, fear of rejection, social withdrawal, and anger, restrictions in lifestyle, problematic family relations, excessive mental engagement in the acne lesions, and depressive and anxiety symptoms can be considered to be the most relevant within these causes. Skaali et al. [30] reported that the level of cancer-related distress in recently diagnosed testicular cancer patients may be related to cognitive impairments. Similarly, Hart et al. [31] examined the role of emotional distress in causing the cognitive impairment that often is apparent in patients with chronic pain, and suggested that pain-related negative emotions and stress may impact cognitive functioning independent of the effects of pain intensity. However, as seen on Table 5, the differences between the performances of the groups in cognitive tests remained significant after controlling for HADS and LSAS scores, which may suggest underlying mechanisms other than psychological distress.

The current study did not test the role of the factors other than psychological distress in performances of acne patients in cognitive tests, but accepting that alternative hypotheses remain just as plausible, we offer oxidative stress (OS) which plays roles in the etiopathogenesis of some dermatological diseases, and significantly impacts neuronal viability and neuroplasticity as a candidate mechanism. OS is defined as “a disturbance in the pro-oxidant–antioxidant balance in favour of the former, leading to potential damage” [32]. Recent studies have concluded that OS plays a pivotal role in the pathogenesis of acne vulgaris, and that increased cutaneous and systemic OS has been shown in the patients with acne [33-35]. The brain is markedly sensitive to oxidative damage since (a) it has a high proportion of polyunsaturated fatty acids, which are highly vulnerable to lipid peroxidation and catecholamines sensitive for autoxidation; (b) it has a high metabolic activity, due to its dependence on large amounts of oxygen; (c) it has a lower activity of glutathione peroxidase and catalase, when compared to other organs, which means it is relatively deficient in antioxidant systems; and (d) its metal components, such as copper and iron, are redox-active metals, which result to the production of free radicals [36]. Recent data also suggest that OS may be involved in the pathophysiology of psychiatric disorders, such as bipolar disorder, schizophrenia, depressive disorders, and anxiety disorder [37]. OS can also cause neuronal toxicity via DNA damage, lipid peroxidation, and reduction in neurotrophins. In the light of these data, OS may be a candidate mechanism responsible for the neuro-structural and cognitive changes in major psychiatric disorders and cognitive disturbances in acne patients, which should be investigated in future studies [38,39].

There are two important limitations of the present study. Firstly, the test batteries did not include all areas of cognitive functioning. This is a consequence of the time required for completion of the test battery. On average, 1 hour was required to complete our battery of tests, and longer test times may have resulted in a fatigue-related decrease in performance. The next limitation was that the visible nature of acne lesions made it impossible to perform the neurocognitive evaluations blind.

In conclusion, we found that cognitive functions are influenced in acne patients with a worse performance when compared to a control group. We suggest that this influence may be related to the psychological distress associated with acne vulgaris, and the underlying metabolic/chemical pathways affecting both the skin and the brain may be related to retinoid signalling, or OS. As acne vulgaris is a disease of adolescence, when academic performance has great importance, psychiatric consultation including cognitive evaluation seems to be critical part of acne treatment.

Further investigations are necessary to develop the links between cognitive functioning and oxidative parameters in acne patients. Neuroimaging studies focusing on the hippocampus and prefrontal cortex should verify our data, and shed further light on the pathogenesis of the impact of acne on the cognitive functions.


The authors declare that they have no competing interests to report. The study was not supported by any funding sources. This study is presented as a poster abstract at the 5th International Congress on Psychopharmacology & International Symposium on Child and Adolescent Psychopharmacology 2013.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12458
  • [From(publication date):
    July-2014 - Aug 16, 2018]
  • Breakdown by view type
  • HTML page views : 8650
  • PDF downloads : 3808

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A


[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


porn sex

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

Gaziantep Escort

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A


[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

mp3 indir

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals


Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T


[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version